Other Systems. If during the term of this Agreement Ciba makes the determination to engage a third party (other than Dermion) to develop a System for a Drug owned, licensed or manufactured by Ciba (other than a Ciba Proprietary Drug for treatment of the Specified Indication, which shall be covered by Section 3.5(a) above) (a "Ciba Proposed System"), prior to initiating discussions with such third party, Ciba shall notify Dermion in writing. Ciba agrees for a period of thirty (30) days from such notice (the "Ciba Standstill Period"), (i) to negotiate in good faith with Dermion to reach an agreement under which Dermion would develop the Ciba Proposed System for Ciba either pursuant to this Agreement or an amendment to this Agreement (provided, that, other than providing for incremental costs to be paid by Ciba and incremental personnel, facilities and resources to be provided by Dermion, such amendment shall be on the same terms and conditions as this Agreement), and
Appears in 2 contracts
Samples: Research and Development Agreement (Iomed Inc), Research and Development Agreement (Iomed Inc)